Nova Lima News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Afya (NASDAQ:AFYA – Get Free Report) and QuantaSing Group (NASDAQ:QSG – Get Free Report) are both small-cap consumer discretionary companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Insider & Institutional Ownership 88.0% of Afya […]

MINUTES OF THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS' MEETING HELD ON APRIL 26, 2024 Date, Time, and Venue: April 26, 2024, at 10:00 a.m., at the headquarters of JBS S.A.,...

Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant. The Government will purchase the entire output to make it available free of charge nationwide for diabetes patients. The facility is said to have cost around R$ 800 million (US$ 156 million) through loans from public banks. The South American country currently imports 95% of the insulin it uses. Some 15.7 million adults are said to have the malady nationwide.

Biocon, an India-based biopharmaceutical company, has entered into an exclusive licensing and supply agreement with Brazilian specialty pharmaceutical company Biomm for the commercialisation of Semaglutide (gOzempic), a drug used to improve glycemic control in adults with type-2 diabetes.

MANAGEMENT'S PROPOSAL FOR THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS' MEETING TO BE HELD ON APRIL 26, 2024 Dear Shareholders, The management of JBS...